Covestro (1COV) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
9 Jul, 2026Strategic partnership and transaction overview
Signed investment agreement with ADNOC, including a voluntary public takeover offer at €62 per share, representing a 54% premium to the unaffected share price as of June 2023 and valuing the company at approximately €11.7 billion.
ADNOC will subscribe to a 10% capital increase at the offer price, providing €1.17 billion in proceeds to support strategic initiatives and Covestro's "Sustainable Future" strategy.
No sale, closure, or significant reduction of business activities is planned; operational management and strategic direction remain unchanged.
ADNOC supports the current business structure, strategy, and vision for full circularity, with commitments to sustainability and growth.
The investment agreement runs until the end of 2028, with no domination or profit and loss transfer agreement during this period.
Governance, employee, and legal assurances
Governance structure, including the co-determined supervisory board and headquarters in Leverkusen, will be maintained; ADNOC will receive 4 out of 12 Supervisory Board seats, and two independent members will remain.
Employee interests are protected, with recognition of existing works agreements, collective bargaining, and works council rights in Germany.
Intellectual property and technology will remain protected, with no transfer to ADNOC or third parties.
The company will remain managed as a German stock corporation, with the current management team continuing to lead.
Disputes under the agreement will be resolved through arbitration.
Offer process, regulatory, and timeline details
Offer subject to a minimum acceptance rate of 50% plus one share and customary closing conditions, including merger control, foreign investment, and EU foreign subsidies clearance.
Main regulatory approvals required in the EU, US, and China.
Initial acceptance period expected to last four to five weeks after offer document publication; closing anticipated in H2 2025.
After the acceptance period, a two-week additional acceptance window will be available for remaining shareholders.
Both Boards of Management and Supervisory Board support the agreement and intend to recommend acceptance to shareholders.
Latest events from Covestro
- EBITDA surged 64.4% to €669 million as margins improved despite lower sales.1COV
Q2 2026 - AGM approved all items as company advances digital, sustainable growth amid ongoing challenges.1COV
AGM 2025 - FY 2025 saw lower sales and earnings, but transformation and climate targets remain on track.1COV
Investor presentation - EBITDA fell 30.9% to €740m as strategic actions and XRG partnership offset weak demand.1COV
Q4 2025 (Media) - Sales and EBITDA declined, but strategic initiatives and cost savings support future growth.1COV
Q4 2025 - Sales and EBITDA fell in Q3 2025, with guidance cut and acquisitions advancing.1COV
Q3 2025 - Q3 volume growth offset price declines; FY 2024 outlook narrowed amid margin pressure.1COV
Q3 2024 - Volume growth offset by lower prices; earnings and guidance down, STRONG program and ADNOC talks underway.1COV
Q2 2024 - Stable EBITDA and volume growth offset price declines; XRG takeover and STRONG program drive outlook.1COV
Q4 2024